All In Biotech

Drugs by condition

Drugs approved for acromegaly

Brand-name prescription drugs and biologics whose FDA label lists acromegaly as an approved use. Matched on the label phrases: "acromegaly".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

10

Still marketed, NDA or BLA

Drug classes

2

Novel drugs

5

New molecular entities and new biologics

In development

4

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for acromegaly.

  • Palsonify (Paltusotine Hydrochloride) · Crinetics NovelOrphanSep 25, 2025
  • Bynfezia Pen (Octreotide Acetate) · Sun Pharm Sep 27, 2024
  • Mycapssa (Octreotide Acetate) · Chiesi OrphanJun 26, 2020
  • Signifor Lar Kit (Pasireotide Pamoate) · Recordati Rare OrphanDec 15, 2014
  • Somatuline Depot (Lanreotide Acetate) · Ipsen Pharma NovelOrphanAug 30, 2007

All approved drugs for acromegaly, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 19 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Somatostatin Analog (1)

  • Mycapssa Octreotide Acetate · Chiesi · 2020

Class not listed in FDA's data (9)

Drugs in development for acromegaly

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CAM2029octreotide depotPhase 33 trials

    Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly

  • SYHX2008Phase 33 trials

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly

  • Debio 4126Phase 31 trial

    Debiopharm International SA · Acromegaly

  • MAR002Phase 21 trial

    Marea Therapeutics · Acromegaly

1 discontinued brand-name drugs whose label still names it

More on acromegaly: recruiting trials · published research

Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Menopause symptoms · Endometriosis · Uterine fibroids · Birth control · Low testosterone · Growth hormone deficiency · Cushing's syndrome

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.